PL370352A1 - Estry analogów 3-dezoksy-witaminy D 3 - Google Patents

Estry analogów 3-dezoksy-witaminy D 3

Info

Publication number
PL370352A1
PL370352A1 PL02370352A PL37035202A PL370352A1 PL 370352 A1 PL370352 A1 PL 370352A1 PL 02370352 A PL02370352 A PL 02370352A PL 37035202 A PL37035202 A PL 37035202A PL 370352 A1 PL370352 A1 PL 370352A1
Authority
PL
Poland
Prior art keywords
desoxy
vitamin
analog esters
esters
analog
Prior art date
Application number
PL02370352A
Other languages
English (en)
Inventor
Milan Radoje Uskokovic
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL370352A1 publication Critical patent/PL370352A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02370352A 2001-09-21 2002-09-12 Estry analogów 3-dezoksy-witaminy D 3 PL370352A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32387001P 2001-09-21 2001-09-21
US32395701P 2001-09-21 2001-09-21

Publications (1)

Publication Number Publication Date
PL370352A1 true PL370352A1 (pl) 2005-05-16

Family

ID=26984180

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370352A PL370352A1 (pl) 2001-09-21 2002-09-12 Estry analogów 3-dezoksy-witaminy D 3

Country Status (14)

Country Link
EP (1) EP1430026A1 (pl)
JP (1) JP2005503434A (pl)
KR (1) KR100628586B1 (pl)
CN (1) CN1285573C (pl)
AU (1) AU2002338672B2 (pl)
BR (1) BR0212719A (pl)
CA (1) CA2459789A1 (pl)
MX (1) MXPA04002640A (pl)
PA (1) PA8554901A1 (pl)
PE (1) PE20030429A1 (pl)
PL (1) PL370352A1 (pl)
RU (1) RU2296121C2 (pl)
UY (1) UY27448A1 (pl)
WO (1) WO2003027065A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05003499A (es) * 2002-10-23 2005-06-17 Leo Pharma As Analogos de vitamina d, composiciones que los comprenden y su uso.
CA2580962A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
WO2010020966A2 (en) 2008-08-22 2010-02-25 Nxp B.V. Location-based services
CN110339205B (zh) * 2019-08-19 2021-08-24 山东德信生物科技有限公司 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
JP4219553B2 (ja) * 1997-09-08 2009-02-04 エフ．ホフマン−ラ ロシュ アーゲー １，３−ジヒドロキシ−２０，２０−ジアルキル−ビタミンｄ３類似体
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs

Also Published As

Publication number Publication date
RU2004112217A (ru) 2005-07-10
WO2003027065A1 (en) 2003-04-03
PA8554901A1 (es) 2003-12-10
KR20040035853A (ko) 2004-04-29
CN1285573C (zh) 2006-11-22
CN1556795A (zh) 2004-12-22
CA2459789A1 (en) 2003-04-03
KR100628586B1 (ko) 2006-09-26
PE20030429A1 (es) 2003-05-15
JP2005503434A (ja) 2005-02-03
EP1430026A1 (en) 2004-06-23
BR0212719A (pt) 2004-08-03
AU2002338672B2 (en) 2006-03-09
RU2296121C2 (ru) 2007-03-27
UY27448A1 (es) 2003-03-31
MXPA04002640A (es) 2004-06-07

Similar Documents

Publication Publication Date Title
AU148030S (en) Pedestal
TW595562U (en) Casket
EP1551384A4 (en) R-NSAID ESTERS AND ITS USE
HRP20041101A2 (en) New etonogestrel esters
GB2390952B (en) Monitor
GB0102212D0 (en) Controller
EP1380924A4 (en) CONTROL
GB0025437D0 (en) Esters
TW501477U (en) Environmental-protected coffin
TW551704U (en) Modular jack
GB2376085B (en) Visual aid
GB0025438D0 (en) Esters
EP1439303A4 (en) AUTOMATIC CONTROL UNIT CONTROL UNIT
AU2003248939A1 (en) Continuous steelmaking plant
EP1353461A4 (en) ANALOG FILTER
DE60231474D1 (en) Monitor
GB2386385B (en) Memorial constructions
GB0204882D0 (en) Pedestal
TW493703U (en) Improved nut
AU2002335702A1 (en) Analog demultiplexer
AU151375S (en) Urn
TW587462U (en) Urn
GB0207311D0 (en) Memorial constructions
AU146027S (en) Urn
AU2002237571A1 (en) Linear Oligolactate Ester

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)